Cerity Partners LLC grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 82.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 130,895 shares of the pharmaceutical company’s stock after acquiring an additional 58,974 shares during the period. Cerity Partners LLC owned […]